Corrigendum: Anti-trypanosomatid drug discovery: An ongoing challenge and a continuing need (Nature Reviews Microbiology (2017) 15 (217-231) DOI: 10.1038/nrmicro.2016.193)

Mark C. Field; David Horn; Alan Fairlamb; Michael Ferguson; David Gray; Kevin Read; Manu De Rycker; Leah Torrie; Paul Wyatt; Susan Wyllie; Ian H. Gilbert

doi:10.1038/nrmicro.2017.69

Corrigendum: Anti-trypanosomatid drug discovery: An ongoing challenge and a continuing need (Nature Reviews Microbiology (2017) 15 (217-231) DOI: 10.1038/nrmicro.2016.193)

Mark C. Field, David Horn, Alan Fairlamb, Michael Ferguson, David Gray, Kevin Read, Manu De Rycker, Leah Torrie, Paul Wyatt, Susan Wyllie, Ian H. Gilbert

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In figure 2b of this article, the structures of Pafuramidine and DB75 were incorrect. The mistakes have been corrected in the PDF and online. The authors apologize to readers for any confusion caused.

Original language	English
Article number	447
Number of pages	1
Journal	Nature Reviews Microbiology
Volume	15
DOIs	https://doi.org/10.1038/nrmicro.2017.69
Publication status	Published - 5 Jun 2017

ASJC Scopus subject areas

Immunology and Microbiology(all)

Access to Document

10.1038/nrmicro.2017.69

Cite this

Field, M. C., Horn, D., Fairlamb, A., Ferguson, M., Gray, D., Read, K., De Rycker, M., Torrie, L., Wyatt, P., Wyllie, S., & Gilbert, I. H. (2017). Corrigendum: Anti-trypanosomatid drug discovery: An ongoing challenge and a continuing need (Nature Reviews Microbiology (2017) 15 (217-231) DOI: 10.1038/nrmicro.2016.193). Nature Reviews Microbiology, 15, [447]. https://doi.org/10.1038/nrmicro.2017.69

@article{c9122b7200bc472eb5e0bc4bf2f9e558,

title = "Corrigendum: Anti-trypanosomatid drug discovery: An ongoing challenge and a continuing need (Nature Reviews Microbiology (2017) 15 (217-231) DOI: 10.1038/nrmicro.2016.193)",

abstract = "In figure 2b of this article, the structures of Pafuramidine and DB75 were incorrect. The mistakes have been corrected in the PDF and online. The authors apologize to readers for any confusion caused.",

author = "Field, {Mark C.} and David Horn and Alan Fairlamb and Michael Ferguson and David Gray and Kevin Read and {De Rycker}, Manu and Leah Torrie and Paul Wyatt and Susan Wyllie and Gilbert, {Ian H.}",

year = "2017",

month = jun,

day = "5",

doi = "10.1038/nrmicro.2017.69",

language = "English",

volume = "15",

journal = "Nature Reviews Microbiology",

issn = "1740-1526",

publisher = "Nature Publishing Group",

}

Field, MC , Horn, D , Fairlamb, A , Ferguson, M , Gray, D , Read, K , De Rycker, M , Torrie, L , Wyatt, P , Wyllie, S & Gilbert, IH 2017, 'Corrigendum: Anti-trypanosomatid drug discovery: An ongoing challenge and a continuing need (Nature Reviews Microbiology (2017) 15 (217-231) DOI: 10.1038/nrmicro.2016.193)', Nature Reviews Microbiology, vol. 15, 447. https://doi.org/10.1038/nrmicro.2017.69

TY - JOUR

T1 - Corrigendum

T2 - Anti-trypanosomatid drug discovery: An ongoing challenge and a continuing need (Nature Reviews Microbiology (2017) 15 (217-231) DOI: 10.1038/nrmicro.2016.193)

AU - Field, Mark C.

AU - Horn, David

AU - Fairlamb, Alan

AU - Ferguson, Michael

AU - Gray, David

AU - Read, Kevin

AU - De Rycker, Manu

AU - Torrie, Leah

AU - Wyatt, Paul

AU - Wyllie, Susan

AU - Gilbert, Ian H.

PY - 2017/6/5

Y1 - 2017/6/5

N2 - In figure 2b of this article, the structures of Pafuramidine and DB75 were incorrect. The mistakes have been corrected in the PDF and online. The authors apologize to readers for any confusion caused.

AB - In figure 2b of this article, the structures of Pafuramidine and DB75 were incorrect. The mistakes have been corrected in the PDF and online. The authors apologize to readers for any confusion caused.

UR - http://www.scopus.com/inward/record.url?scp=85020747150&partnerID=8YFLogxK

U2 - 10.1038/nrmicro.2017.69

DO - 10.1038/nrmicro.2017.69

M3 - Comment/debate

AN - SCOPUS:85020747150

SN - 1740-1526

VL - 15

JO - Nature Reviews Microbiology

JF - Nature Reviews Microbiology

M1 - 447

ER -

Corrigendum: Anti-trypanosomatid drug discovery: An ongoing challenge and a continuing need (Nature Reviews Microbiology (2017) 15 (217-231) DOI: 10.1038/nrmicro.2016.193)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need

Cite this